Antibodies to chemokine β-15
    22.
    发明授权
    Antibodies to chemokine β-15 失效
    趋化因子抗体; -15

    公开(公告)号:US07829293B2

    公开(公告)日:2010-11-09

    申请号:US11537681

    申请日:2006-10-02

    CPC分类号: C07K14/523

    摘要: The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine β-15 protein. Chemokine β-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

    摘要翻译: 本发明涉及人趋化因子CC蛋白家族的成员。 特别地,提供编码趋化因子和bgr-15蛋白的分离的核酸分子。 还提供了趋化因子和bgr-15多肽。 本发明还涉及用于检测胸腺疾病的诊断方法和用于调节骨髓细胞增殖和分化的治疗方法。

    Chemokine β-15
    23.
    发明授权

    公开(公告)号:US07135551B2

    公开(公告)日:2006-11-14

    申请号:US10263766

    申请日:2002-10-04

    IPC分类号: C07K14/475

    CPC分类号: C07K14/523

    摘要: The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine β-15 protein. Chemokine β-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

    Polynucleotides encoding chemokine &bgr;-15
    24.
    发明授权
    Polynucleotides encoding chemokine &bgr;-15 失效
    编码趋化因子β-15的多核苷酸

    公开(公告)号:US06503735B2

    公开(公告)日:2003-01-07

    申请号:US09272162

    申请日:1999-03-19

    IPC分类号: C12N121

    CPC分类号: C07K14/523

    摘要: The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine &bgr;-15 protein. Chemokine &bgr;-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

    摘要翻译: 本发明涉及人趋化因子CC蛋白家族的成员。 特别地,提供编码趋化因子β-15蛋白的分离的核酸分子。 还提供趋化因子β-15多肽。 本发明还涉及用于检测胸腺疾病的诊断方法和用于调节骨髓细胞增殖和分化的治疗方法。

    Polynucleotides encoding chemokine .beta.-15
    29.
    发明授权
    Polynucleotides encoding chemokine .beta.-15 失效
    编码趋化因子β的多核苷酸-15

    公开(公告)号:US5981231A

    公开(公告)日:1999-11-09

    申请号:US874460

    申请日:1997-06-16

    CPC分类号: C07K14/523

    摘要: The present invention concerns a member of the human chemokine CC protein family. In particular isolated nucleic acid molecules are provided encoding the chemokine .beta.-15 protein. Chemokine .beta.-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

    摘要翻译: 本发明涉及人趋化因子CC蛋白家族的成员。 特别提供编码趋化因子β-15蛋白的分离的核酸分子。 也提供趋化因子β-15多肽。 本发明还涉及用于检测胸腺疾病的诊断方法和用于调节骨髓细胞增殖和分化的治疗方法。

    Methods of treatment with TNFR5
    30.
    发明授权
    Methods of treatment with TNFR5 失效
    TNFR5治疗方法

    公开(公告)号:US07511017B2

    公开(公告)日:2009-03-31

    申请号:US11182946

    申请日:2005-07-18

    摘要: The present invention relates to a novel human gene encoding a polypeptide which is a member of the TNF receptor family, and has now been found to bind TRAIL. More specifically, an isolated nucleic acid molecule is provided encoding a human polypeptide named tumor necrosis factor receptor-5, sometimes referred to as “TNFR-5” or “TR5,” and now referred to hereinafter as “TRAIL receptor without intracellular domain” or “TRID.” TRID polypeptides are also provided, as are vectors, host cells, and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists or antagonists of TRAIL polypeptide activity. Also provided are diagnostic and therapeutic methods utilizing such compositions.

    摘要翻译: 本发明涉及编码作为TNF受体家族成员的多肽的新型人基因,现已发现其结合TRAIL。 更具体地,提供编码称为肿瘤坏死因子受体-5(有时称为“TNFR-5”或“TR5”)的人多肽的分离的核酸分子,以下在下文中称为“没有细胞内结构域的TRAIL受体”或 “TRID”。 还提供了TRID多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 本发明还涉及用于鉴定TRAIL多肽活性的激动剂或拮抗剂的筛选方法。 还提供了利用这种组合物的诊断和治疗方法。